H.R. 9525 – Continuing Appropriations and Health Extenders Act of 2022

AI-Generated Summary

Updated February 8, 2026 at 6:47 PM UTC

The Continuing Appropriations and Health Extenders Act of 2022 temporarily extends a range of federal appropriations and health‑related program authorizations that were set to expire in December 2022, pushing their deadlines to early February 2023. It affects agencies that run Medicare, Medicaid, FCC auctions, anti‑trafficking funds, and various health research and drug programs, and it also requires the Office of Management and Budget to release a 2022 PAYGO report.

Key Provisions

Extends the Continuing Appropriations and Ukraine Supplemental Appropriations Act deadline from Dec. 16, 2022 to Feb. 3, 2023.
Orders the OMB to publish the 2022 PAYGO report and any required order by Feb. 4, 2023.
Extends FCC auction authority, the domestic trafficking victims’ fund, and the CFTC customer‑protection fund deadline to Feb. 3, 2023.
Extends Medicare and Medicaid payment adjustments for low‑volume hospitals, the Medicare‑Dependent Hospital program, and increased FMAP for territories to early February 2023.
Continues maternal, infant, and early childhood home‑visiting programs, child and family services, and the Alaska Native village health moratorium through Feb. 3, 2023, with appropriate funding.
Reauthorizes and raises funding for several health initiatives—including the Best Pharmaceuticals for Children program, Humanitarian Device Exemption, Pediatric Device Consortia, Critical Path partnership, and Orphan Drug grants—up to Feb. 3, 2023.
Extends various FDA reporting, device inspection, and generic drug application deadlines to early February 2023.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

1 earlier action

HouseIntro Referral Latest Action

Referred to the Committee on Appropriations, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Appropriations Committee

December 14, 2022

View full timeline

HouseIntro Referral

Introduced in House

December 14, 2022

HouseIntro Referral

Referred to the Committee on Appropriations, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Appropriations Committee

December 14, 2022

Floor Debate

1 member

What members said about H.R. 9525 on the floor

1 Republican

Rep. Chip RoyR-TX-21 · Dec 14, 2022

Mr. Speaker, I ask unanimous consent to call up H.R. 9525 to extend the funding of government through February 3, 2023.

Bill Text

Latest available legislative text

Reading Mode

Raw Text PDF XML

Introduced in HouseIssued December 14, 2022

I

117th CONGRESS

2d Session

H. R. 9525

IN THE HOUSE OF REPRESENTATIVES

December 14, 2022

Mr. Roy introduced the following bill; which was referred to the Committee on Appropriations, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

A BILL

Making continuing appropriations for fiscal year 2023, extending various health programs, and for other purposes.

1.

Short title

This Act may be cited as the Continuing Appropriations and Health Extenders Act of 2022.

I

Continuing appropriations

101.

Extension of appropriations

Section 106(3) of division A of the Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 (Public Law 117–180; 136 Stat. 2116) is amended by striking December 16, 2022 and inserting February 3, 2023.

102.

PAYGO report

Notwithstanding subsection (a) of section 5 of the Statutory Pay-As-You-Go Act of 2010 (2 U.S.C. 934), the Office of Management and Budget shall make publicly available the annual PAYGO report required under such subsection for 2022 and prepare any order required under subsection (b) of such section not later than February 4, 2023.

II

Extensions, Technical Corrections, and Other Matters

201.

Extension of FCC Auction Authority

Section 309(j)(11) of the Communications Act of 1934 (47 U.S.C. 309(j)(11)) is amended by striking December 16, 2022 and inserting February 3, 2023.

202.

Extension of Authorization for Special Assessment for Domestic Trafficking Victims’ Fund

Section 3014(a) of title 18, United States Code, is amended, in the matter preceding paragraph (1), by striking December 16, 2022 and inserting February 3, 2023.

203.

Extension of Commodity Futures Trading Commission Customer Protection Fund Expenses Account

Section 1(b) of Public Law 117–25 (135 Stat. 297) is amended by striking December 16, 2022 each place it appears and inserting February 3, 2023.

III

Health and Human Services Extensions

A

Medicare and Medicaid

301.

Extension of increased inpatient hospital payment adjustment for certain low-volume hospitals

(a)

In general

Section 1886(d)(12) of the Social Security Act (42 U.S.C. 1395ww(d)(12)) is amended—

(1)

in subparagraph (B), in the matter preceding clause (i), by striking December 17, 2022 and inserting February 4, 2023;

(2)

in subparagraph (C)(i)—

(A)

in the matter preceding subclause (I), by striking December 16, 2022 and inserting February 3, 2023;

(B)

in subclause (III), by striking December 16, 2022 and inserting February 3, 2023; and

(C)

in subclause (IV), by striking December 17, 2022 and inserting February 4, 2023; and

(3)

in subparagraph (D)—

(A)

in the matter preceding clause (i), by striking December 16, 2022 and inserting February 3, 2023; and

(B)

in clause (ii), by striking December 16, 2022 and inserting February 3, 2023.

(b)

Implementation

Notwithstanding any other provision of law, the Secretary of Health and Human Services may implement the provisions of, including the amendments made by, this section by program instruction or otherwise.

302.

Extension of the Medicare-dependent hospital (MDH) program

(a)

In general

Section 1886(d)(5)(G) of the Social Security Act (42 U.S.C. 1395ww(d)(5)(G)) is amended—

(1)

in clause (i), by striking December 17, 2022 and inserting February 4, 2023; and

(2)

in clause (ii)(II), by striking December 17, 2022 and inserting February 4, 2023.

(b)

Conforming amendments

(1)

Extension of target amount

Section 1886(b)(3)(D) of the Social Security Act (42 U.S.C. 1395ww(b)(3)(D)) is amended—

(A)

in the matter preceding clause (i), by striking December 17, 2022 and inserting February 4, 2023; and

(B)

in clause (iv), by striking December 16, 2022 and inserting February 3, 2023.

(2)

Permitting hospitals to decline reclassification

Section 13501(e)(2) of the Omnibus Budget Reconciliation Act of 1993 (42 U.S.C. 1395ww note) is amended by striking December 16, 2022 and inserting February 3, 2023.

303.

Extension of increased FMAPs for the territories

Section 1905(ff) of the Social Security Act (42 U.S.C. 1396d(ff)) is amended by striking December 16, 2022 each place it appears and inserting February 3, 2023 in each such place.

B

Human Services

311.

Extension of maternal, infant, and early childhood home visiting programs

Activities authorized by section 511 of the Social Security Act shall continue through February 3, 2023, in the manner authorized for fiscal year 2022, and out of any money in the Treasury of the United States not otherwise appropriated, there is hereby appropriated for such purpose an amount equal to the pro rata portion of the amount appropriated for such activities for fiscal year 2022.

312.

Extension of child and family services programs

Activities authorized by part B of title IV of the Social Security Act shall continue through February 3, 2023, in the manner authorized for fiscal year 2022, and out of any money in the Treasury of the United States not otherwise appropriated, there are hereby appropriated such sums as may be necessary for such purpose.

C

Indian Health

321.

Extension of moratorium relating to funds for health care services for certain Alaska Native villages

Section 424(a) of the Department of the Interior, Environment, and Related Agencies Appropriations Act, 2014 (Public Law 113–76; 128 Stat. 343; 132 Stat. 693; 136 Stat. 2136) is amended by striking December 16, 2022 and inserting February 3, 2023.

IV

Reauthorization of other provisions

401.

Reauthorization of the best pharmaceuticals for children program

Section 409I(d)(1) of the Public Health Service Act (42 U.S.C. 284m(d)(1)) is amended by striking $5,273,973 for the period beginning on October 1, 2022 and ending on December 16, 2022 and inserting $8,630,138 for the period beginning on October 1, 2022, and ending on February 3, 2023.

402.

Reauthorization of the humanitarian device exemption incentive

Section 520(m)(6)(A)(iv) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360j(m)(6)(A)(iv)) is amended by striking December 17, 2022 and inserting February 4, 2023.

403.

Reauthorization of the pediatric device consortia program

Section 305(e) of the Food and Drug Administration Amendments Act of 2007 (Public Law 110–85; 42 U.S.C. 282 note) is amended by striking $1,107,534 for the period beginning on October 1, 2022, and ending on December 16, 2022 and inserting $1,812,328 for the period beginning on October 1, 2022, and ending on February 3, 2023.

404.

Reauthorization of provision pertaining to drugs containing single enantiomers

Section 505(u)(4) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(u)(4)) is amended by striking December 17, 2022 and inserting February 4, 2023.

405.

Reauthorization of the critical path public-private partnership

Section 566(f) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb–5(f)) is amended by striking $1,265,753 for the period beginning on October 1, 2022 and ending on December 16, 2022 and inserting $2,071,232 for the period beginning on October 1, 2022, and ending on February 3, 2023.

406.

Reauthorization of orphan drug grants

Section 5(c) of the Orphan Drug Act (21 U.S.C. 360ee(c)) is amended by striking $6,328,767 for the period beginning on October 1, 2022, and ending on December 16, 2022 and inserting $10,356,164 for the period beginning on October 1, 2022, and ending on February 3, 2023.

407.

Reauthorization of certain device inspections

Section 704(g)(11) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 374(g)(11)) is amended by striking December 17, 2022 and inserting February 4, 2023.

408.

Reauthorization of reporting requirements related to pending generic drug applications and priority review applications

Section 807 of the FDA Reauthorization Act of 2017 (Public Law 115–52) is amended, in the matter preceding paragraph (1), by striking December 16, 2022 and inserting February 3, 2023.